PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Clinical trials for PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy aims to reset immune system in devastating autoimmune diseases
Disease control Recruiting nowThis study is testing a new cell therapy called CD19-BCMA CAR-T for people with severe autoimmune diseases that have not responded to standard treatments. It aims to see if this therapy is safe and can help control diseases like lupus affecting the kidneys, systemic sclerosis, an…
Matched conditions: PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Revolutionary Cancer-Fighting therapy tested for devastating autoimmune diseases
Disease control Recruiting nowThis study is testing a new cell therapy, originally developed for cancer, for people with severe autoimmune diseases that haven't responded to standard treatments. It uses modified immune cells (CAR-T) from umbilical cord blood to try to reset the body's faulty immune system. Th…
Matched conditions: PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC